Invest

Advertisement · Advance information on a planned investment opportunityDE EN FR

Equity round · Priority list for investors

Become a co-owner of a Swiss premium skincare brand. Before it gets big.

Complice already sells in Switzerland and London, with gross margins of up to 93 percent. Now the company is opening its capital for the first time. If you are on the priority list, you receive the documents first and can invest at the preferential price.

Complice AM Serum on marble in front of a Swiss mountain landscape
Gross margin per product
80 to 93 %
Pre-money valuation
CHF 2.1 M
Pre-funding discount
−14 %
Invest from
CHF 252

The opportunity

Between prestige and mass market, there is room for a Swiss brand.

Anyone looking for skincare at the highest level often pays several hundred francs today, mostly for a name. Clean beauty brands are cheaper but rarely offer the standard of luxury care. Complice fills exactly this gap: formulated by a Swiss scientist, made in Switzerland, vegan, at prices between CHF 49.90 and 169.90.

The tailwind comes from the market: according to market studies, natural cosmetics grow by around 9.5 % per year, roughly three times as fast as the skincare market as a whole (around 3 %).1

Complice was founded by Nives and Shane De Souza. Nives spent years looking for skincare that delivers what it promises. Today she runs the company and has personally won its international retail partners.

Already proven

Not an idea on paper. A brand that has convinced buyers.

On board SWISS

Sold in travel retail, one of the two largest channels in 2025.

John Bell & Croyden, London

328 units sold in eleven months at the historic pharmacy.

TK Maxx

Sold through international off-price retail.

CHF 182,000

Product revenue 2025 (cash basis), with a positive operating cash result. Built with a very small marketing budget.

Proprietary formulas

Four products, formulas fully owned by the company.

Protected brand

Trademark and product registrations for Switzerland, the EU, the UK, China and India.

The business model

High margin per product. Lean structure.

Production is handled by an established Swiss manufacturer, the company's own organisation stays small. Sales run through two channels: the own online shop with the highest margin and retail for reach. The online channel is exactly what has never been funded. This is where the round comes in.

Produit Prix Gross margin
PM Serum “Reset” CHF 169.90 93 %
AM Serum “Glow” CHF 149.90 93 %
24H Moisturiser CHF 79.90 85 %
Cleanser CHF 49.90 80 %

Gross margin based on the retail price; correspondingly lower in wholesale.

The plan

From proven product to scaled distribution.

With this round, Complice builds its own online sales, reactivates the retail channels from existing stock and reorders production. According to the business plan, the company is expected to be EBITDA positive in 2027 and to reach net revenue of around CHF 2.9 M by 2030.

The plan assumes full build-out. The crowdinvesting round funds the first phase; a follow-on round is planned for 2027 for the second.

Net revenue in CHF · actual and plan

Actual (cash basis) Plan · indicative, no guarantee

The return case

What your investment could become.

Complice does not plan any distributions in the coming years; profits go into growth. Your return comes from the increase in the company's value. Premium beauty brands are typically valued at 2 to 4 times their revenue in transactions. Applied to the 2030 plan, this gives the following illustrative scenarios.

CHF
CHF 5,040
Entry

280 participation certificates

Plan missed

Loss possible

up to a total loss

Conservative · 2× revenue

Base · 3× revenue

Optimistic · 4× revenue

Illustrative calculation, not a forecast and not a guarantee. Assumptions: 2030 net revenue per business plan CHF 2.86 M; company value = revenue × multiple, ignoring debt and cash; 111,905 shares after a CHF 250,000 round; 20 % dilution from the planned 2027 follow-on round; no taxes or fees. Value is only realised for investors when shares or the company are sold. Neither is guaranteed. Participation certificates are not listed and only transferable to a limited extent.

Planned key terms

Transparent from the start.

The round is planned via the Swiss crowdinvesting platform Conda. Anyone on the priority list is personally invited before launch and can subscribe in pre-funding at the preferential price.

Issuer
Complice Group AG (in formation), Canton of Schwyz
Instrument
Participation certificates: same rights to profit and liquidation proceeds as shares, without voting rights
Pre-money valuation
CHF 2.1 M (CHF 1.8 M in pre-funding)
Price per certificate
CHF 18 in pre-funding · CHF 21 in the public campaign
Investment
from CHF 252 up to CHF 50,400
Round size
Target CHF 250,000 · Maximum CHF 400,000
Timeline
Pre-funding planned from October 2026
Perks
Personal Complice number, investor discount and, depending on the amount, products, investor evening or dinner with the founders

The team

Product, brand, finance and fundraising. All in-house.

  • Nives De SouzaCo-Founder & CEO

    Over 15 years of international business development. Personally won Complice's retail partners.

  • Shane De SouzaCo-Founder & CMO

    Over 15 years in sales, logistics and marketing. Responsible for brand and content.

  • Roman KochCFO

    Certified auditor. Responsible for finance, legal and governance.

  • Daniel JägerCOO & Fundraising

    Over 20 years in finance and digital, has led crowdinvesting campaigns raising over CHF 1 M.

To be honest

What you should know.

  • In 2025, around 81 % of revenue came from two retail partners that are currently paused. 2026 is a deliberate transition year with low revenue.
  • Online sales are being rebuilt; reliable track record is still missing.
  • The business plan assumes a follow-on round in 2027. It may dilute your stake.
  • No distributions are planned in the coming years. Participation certificates are not listed and only transferable to a limited extent.
  • Like any investment in a young company, this one carries risks up to a total loss. Only invest money you can afford to lose.

Priority list

Secure your priority access.

Register without obligation and tell us the range in which you could imagine investing. Nives will contact you personally as soon as the documents are ready.

  • Invitation to pre-funding at the preferential price of CHF 18
  • Business plan and investment documents before anyone else
  • Personal call with the founding team on request

Non-binding expression of interest. Not an offer, not investment advice.

Advertisement within the meaning of the Swiss Financial Services Act (FinSA). This page serves solely to provide information about a planned investment opportunity and constitutes neither an offer nor a solicitation to subscribe for securities, nor investment advice. The official investment documents, which will be made available before launch, are solely authoritative. Terms are planned and subject to change. All plan figures and scenarios are indicative and no guarantee of future results. The offering is aimed at persons resident in Switzerland.

1 Precedence Research (natural and organic cosmetics, CAGR 2025 to 2034); Grand View Research (skincare overall, CAGR 2026 to 2033). 2025 revenue on a cash basis, audited accounts in preparation.